Adjuvant chemotherapy may have no significant survival benefit in older patients with stage II/III gastric cancer: a multicenter retrospective study

被引：0
|
作者：
Zheng-Zheng Shen [1 ]
En-Ze Li [2 ]
Ruo-Lan Zhang [3 ]
Meng-Xuan Cao [2 ]
Yan-Qiang Zhang [2 ]
Qing Yang [2 ]
Can Hu [2 ]
Si-Wei Pan [3 ]
Zhi-Yuan Xu [2 ]
Zai-Sheng Ye [2 ]
Jing-Yang He [2 ]
机构：
[1] Department of Radiation Physics,Department of Gastric Surgery
[2] Zhejiang Cancer Hospital,Department of Gastric Surgery
[3] Hangzhou Institute of Medicine (HIM),undefined
[4] Chinese Academy of Sciences,undefined
[5] Zhejiang Cancer Hospital,undefined
[6] Hangzhou Institute of Medicine (HIM),undefined
[7] Chinese Academy of Sciences,undefined
[8] Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital),undefined
[9] Clinical Oncology School of Fujian Medical University,undefined
[10] Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center),undefined
来源：
Journal of Cancer Research and Clinical Oncology | / 151卷 / 5期
关键词：
Gastric cancer; Adjuvant chemotherapy; Elderly patients;
D O I：
10.1007/s00432-025-06230-w
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Real-world evidence on adjuvant chemotherapy in older adults with stage II/III colon cancer
    Batra, Atul
    Rigo, Rodrigo
    Sheka, Dropen
    Cheung, Winson Y.
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (06) : 604 - 618
  • [42] Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer
    Liu, Qi
    Luo, Dakui
    An, Hongyin
    Zhang, Sheng
    Cai, Sanjun
    Li, Qingguo
    Li, Xinxiang
    JOURNAL OF CANCER, 2019, 10 (05): : 1209 - 1215
  • [43] Outcome predictors for patients with stage II/III gastric cancer who undergo gastrectomy and S-1 adjuvant chemotherapy
    Fujiwara, Yoshinori
    Fukuda, Shuichi
    Tsujie, Masanori
    Kitani, Kotaro
    Inoue, Keisuke
    Hayashi, Tomonori
    Ishikawa, Hajime
    Yukawa, Masao
    Inoue, Masatoshi
    ONCOLOGY LETTERS, 2017, 14 (02) : 1621 - 1627
  • [44] The Prognostic Importance of Microsatellite Instability Status in Turkish Stage II and III Gastric Cancer Patients who Received Adjuvant Chemotherapy
    Arici, Serdar
    Erhan, Selma Sengiz
    Geredeli, Caglayan
    Atci, Muhammed Mustafa
    Secmeler, Saban
    Cekin, Ruhper
    Sakin, Abdullah
    Cihan, Sener
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2021, 31 (01): : 36 - 42
  • [45] The Role of Adjuvant Chemotherapy for Patients with Stage IB Gastric Cancer
    Toyokawa, Takahiro
    Ohira, Masaichi
    Sakurai, Katsunobu
    Kubo, Naoshi
    Tanaka, Hiroaki
    Muguruma, Kazuya
    Hirakawa, Kosei
    ANTICANCER RESEARCH, 2015, 35 (07) : 4091 - 4097
  • [46] Interaction analysis of high-risk pathological features on adjuvant chemotherapy survival benefit in stage II colon cancer patients: a multi-center, retrospective study
    Kexuan Li
    Fuqiang Zhao
    Yuchen Guo
    Qingbin Wu
    Shuangling Luo
    Junling Zhang
    Heli Li
    Shidong Hu
    Bin Wu
    Guole Lin
    Huizhong Qiu
    Beizhan Niu
    Xiyu Sun
    Lai Xu
    Junyang Lu
    Xiaohui Du
    Zheng Wang
    Xin Wang
    Liang Kang
    Ziqiang Wang
    Quan Wang
    Qian Liu
    Yi Xiao
    BMC Cancer, 23 (1)
  • [47] Interaction analysis of high-risk pathological features on adjuvant chemotherapy survival benefit in stage II colon cancer patients: a multi-center, retrospective study
    Li, Kexuan
    Zhao, Fuqiang
    Guo, Yuchen
    Wu, Qingbin
    Luo, Shuangling
    Zhang, Junling
    Li, Heli
    Hu, Shidong
    Wu, Bin
    Lin, Guole
    Qiu, Huizhong
    Niu, Beizhan
    Sun, Xiyu
    Xu, Lai
    Lu, Junyang
    Du, Xiaohui
    Wang, Zheng
    Wang, Xin
    Kang, Liang
    Wang, Ziqiang
    Wang, Quan
    Liu, Qian
    Xiao, Yi
    BMC CANCER, 2023, 23 (01)
  • [48] Immunoscore is a strong predictor of survival in the prognosis of stage II/III gastric cancer patients following 5-FU-based adjuvant chemotherapy
    Sumi Yun
    Jiwon Koh
    Soo Kyung Nam
    Yoonjin Kwak
    Sang-Hoon Ahn
    Joong Do Park
    Hyung-Ho Kim
    Woo Ho Kim
    Hye Seung Lee
    Cancer Immunology, Immunotherapy, 2021, 70 : 431 - 441
  • [49] Preoperative low skeletal muscle volume can result in insufficient administration of S-1 adjuvant chemotherapy in older patients with stage II/III gastric cancer
    Yusuke Kono
    Tomoyuki Matsunaga
    Masahiro Makinoya
    Shota Shimizu
    Yuji Shishido
    Kozo Miyatani
    Kyoichi Kihara
    Manabu Yamamoto
    Shuichi Takano
    Naruo Tokuyasu
    Teruhisa Sakamoto
    Toshimichi Hasegawa
    Yoshiyuki Fujiwara
    Surgery Today, 2024, 54 : 340 - 346
  • [50] Survival of Adjuvant Chemotherapy Among Elderly Patients with Stage II Colon Cancer
    Tsai, Tsung-Chih
    Sun, Jia-Ling
    Lin, Wen-Li
    Lee, Sung-Wei
    Chang, Shu-Chan
    Wu, Pei-Hua
    Huang, Wen-Tsung
    Tsao, Chao-Jung
    INTERNATIONAL JOURNAL OF GERONTOLOGY, 2018, 12 (02) : 94 - 99
12345